Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
PBE
33
HOLDINGS
55%
ALSO IN FTXH
FTXH
50
HOLDINGS
33%
ALSO IN PBE
SECTOR DRIFT (PBE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 4.9% | 3.5% | 3.5% |
|
BIOGEN IDEC INC | 4.9% | 3.5% | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 5.0% | 3.4% | 3.4% |
|
REGENERON PHARMACEUTICALS | 4.7% | 3.3% | 3.3% |
|
GILEAD SCIENCES INC | 4.5% | 3.0% | 3.0% |
PBE Overweight Relative to FTXH
|
ROYALTY PHARMA PLC CLASS A | 4.8% |
|
ALNYLAM PHARMACEUTICALS INC | 4.3% |
|
CAREDX, INC. | 3.2% |
|
VERACYTE INC | 3.2% |
|
BIO-TECHNE CORPORATION | 3.2% |
|
VERICEL CORPORATION | 3.0% |
|
REPLIGEN CORP | 3.0% |
|
BIOCRYST PHARMACEUTICALS INC | 2.8% |
|
SAREPTA THERAPEUTICS INC | 2.8% |
|
ANAPTYSBIO, INC. | 2.6% |
PBE Underweight Relative to FTXH
|
MERCK & CO. INC. | -7.7% |
|
ELI LILLY & CO | -7.4% |
|
ABBVIE INC | -7.1% |
|
JOHNSON & JOHNSON | -6.8% |
|
BRISTOL-MYERS SQUIBB CO | -6.7% |
|
VIATRIS, INC. | -3.4% |
|
PFIZER INC | -3.2% |
|
CARDINAL HEALTH INC | -3.1% |
 |
JAZZ PHARMACEUTICALS PLC | -2.4% |
|
ZOETIS INC | -1.8% |